Adnomyosis
Conditions
Interventions
Control Group:Oral dienogest, once daily, one capsule each time for 6 month
Experimental Group:HIFU treatment, oral dienogest the next day after HIFU, once daily, one capsule each time for 6 month
Sponsors
Shanghai First Maternity and Infant Hospital
Eligibility
Sex/Gender
Female
Age
25 Years to 50 Years
Inclusion criteria
Inclusion criteria: Women of childbearing age, 25-50 years old; Adenomyosis was diagnosed according to clinical symptoms, gynecological B-ultrasound or pelvic plain scan + enhanced magnetic resonance imaging (MRI) ; Willing to receive high-intensity focused ultrasound therapy or oral dienogest therapy; All patients and their family members were informed of the study and signed informed consent voluntarily.
Exclusion criteria
Exclusion criteria: Patients with contraindications to oral medicine therapy, such as severe liver and kidney function impairment, thrombotic disease history, etc.; Patients with contraindications to HIFU treatment, such as history of connective tissue, radiotherapy, language communication disorders, and inability to cooperate with sedation and analgesia programs; Reluctant to accept interviewers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Uterine volume; | — |
Secondary
| Measure | Time frame |
|---|---|
| Visual Analogue Scale ;carbohydrate antigen 125 (CA125); | — |
Countries
China
Contacts
Public ContactXiaofei Zhang
Shanghai First Maternity and Infant Hospital
Outcome results
None listed